Lifeforce and Toku Partner to Use AI Retinal Scans for Health Insights
Lifeforce and Toku have announced a nationwide partnership to integrate AI retinal scans with the world's largest longevity medicine platform. Announced in a press release, this collaboration aims to transform routine eye exams into opportunities for early health insights and proactive intervention.
The partnership will leverage Toku's BioAge™ wellness product and its forthcoming CLAiR™ technology, which has received the FDA Breakthrough Device designation. CLAiR™ is designed to assess cardiovascular risk using retinal imaging and AI, with anticipated FDA approval in 2026.
Through this collaboration, individuals who undergo a BioAge analysis will be connected to Lifeforce's comprehensive longevity platform. This platform offers at-home diagnostics, access to board-certified longevity physicians, and personalized health protocols, enabling participants to take data-driven steps toward extending their healthspan.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Oracle and Buck Institute Use Health Data for Aging Research
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
Insilico Medicine Opens AI Longevity Research Toolkit
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
Linearis Joins Two Canadian AI Health Data Projects
Daily AI Brief: the AI news that matters, in your inbox.